Randomized trials: single ASCT versus conventional chemotherapy
| Reference . | CR, % . | Median PFS, mo . | Median OS, mo . |
|---|---|---|---|
| Attal et al23 (1996) | 22 vs 5 | 28 vs 18 | 57 vs 42 |
| Child et al24 (2003) | 44 vs 9 | 32 vs 20 | 55 vs 42 |
| Bladé et al25 (2005) | 30 vs 11 | 42 vs 34 | 67 vs 65 |
| Fermand et al26 (2005) | 8.5 vs 7 | 25 vs 19 | 47.8 vs 47.6 |
| Barlogie et al27 (2006) | 17 vs 15 | 25 vs 21 | 58 vs 53 |
| Reference . | CR, % . | Median PFS, mo . | Median OS, mo . |
|---|---|---|---|
| Attal et al23 (1996) | 22 vs 5 | 28 vs 18 | 57 vs 42 |
| Child et al24 (2003) | 44 vs 9 | 32 vs 20 | 55 vs 42 |
| Bladé et al25 (2005) | 30 vs 11 | 42 vs 34 | 67 vs 65 |
| Fermand et al26 (2005) | 8.5 vs 7 | 25 vs 19 | 47.8 vs 47.6 |
| Barlogie et al27 (2006) | 17 vs 15 | 25 vs 21 | 58 vs 53 |
ASCT indicates autologous stem cell transplantation; CR, complete remission; EFS, event-free survival; and OS, overall survival.